High-throughput evolutionary optimization of the induction medium towards recombinant protein production in BY-2 tobacco.


Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
02 2021
Historique:
received: 13 08 2020
revised: 05 10 2020
accepted: 09 10 2020
pubmed: 11 10 2020
medline: 26 11 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

Bright yellow (BY-2) tobacco cells combined with the XVE chemically inducible system are one of the most promising plant-based platforms for recombinant protein production. This offers a range of benefits, including the separation of the cell growth and heterologous gene expression, lack of risk of infecting the end product with prions and human viruses or appropriate protein glycosylation and folding. However, low protein productivity remains a major obstacle that limits the extensive commercialization of bioproduction in plants. A number of molecular, cell culture and down processing approaches have been made to overcome this problem. Media development for the specific nutritional and hormonal requirements of transgenic plant cells is one of the most efficient cell-culture approaches. We optimized the induction medium towards recombinant protein production in BY-2 and demonstrated the usefulness of evolutionary medium optimization for high-yield protein production in liquid plant cultures. A reliable XVE/GFP model, parallel conducting experiments in a microscale on 96-well plates, and dedicated Gene Game evolutionary optimization software allowed for an effective search of 76

Identifiants

pubmed: 33038011
doi: 10.1002/bit.27594
doi:

Substances chimiques

Culture Media 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

676-689

Subventions

Organisme : National Science Centre (NCN) of Poland
ID : DEC-2013/09/D/NZ1/03364
Organisme : National Centre for Research and Development (NCBR) of Poland
ID : STRATEGMED1/233624/5/NCBR/2014

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

An, G. (1985). High efficiency transformation of cultured tobacco cells. Plant Physiology, 79, 568-570.
Bugos, R. C., Chang, S. H., & Yamamoto, H. Y. (1999). Developmental expression of violaxanthin de-epoxidase in leaves of tobacco growing under high and low light. Plant Physiology, 121, 207-213.
Buyel, J. F., Twyman, R. M., & Fischer, R. (2017). Very-large-scale production of antibodies in plants: The biologization of manufacturing. Biotechnology Advances, 35, 458-465.
Deineko, E. V., & Zagorskaya, A. A. (2017). Plant expression systems for production of recombinant pharmaceutically important proteins. Vavilovskii Zhurnal Genetiki i Selektsii, 21, 979-985.
Desai, P. N., Shrivastava, N., & Padh, H. (2010). Production of heterologous proteins in plants: Strategies for optimal expression. Biotechnology Advances, 28, 427-435.
Doran (2000). Foreign protein production in plant tissue cultures. Current Opinion in Biotechnology, 11, 199-204.
Fischer, R., & Buyel, J. F. (2020). Molecular farming: The slope of enlightenment. Biotechnology Advances, 40, 107519.
Franco-Lara, E., Link, H., & Weuster-Botz, D. (2006). Evaluation of artificial neural networks for modelling and optimization of medium composition with a genetic algorithm. Process Biochemistry, 41, 2200-2206.
García-Camacho, F., Gallardo-Rodríguez, J. J., Sá Nchez-Miró, A., Chisti, Y., & Molina-Grima, E. (2011). Genetic algorithm-based medium optimization for a toxic dinoflagellate microalga. Harmful Algae, 10, 697-701.
Gleba, Y., Klimyuk, V., & Marillonnet, S. (2005). Magnifection: A new platform for expressing recombinant vaccines in plants. Vaccine, 23, 2042-2048.
Goldberg, D. E. (1989). Genetic algorithms in search, optimisation, and machine learning. Addison-Wesley Publishing Company Inc.
Gomord, V., Fitchette, A. C., Menu-Bouaouiche, L., Saint-Jore-Dupas, C., Plasson, C., Michaud, D., & Faye, L. (2010). Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnology Journal, 8, 564-587.
Hellwig, S., Drossard, J., Twyman, R. M., & Fischer, R. (2004). Plant cell cultures for the production of recombinant proteins. Nature Biotechnology, 22, 1415-1422.
Holland, J. H. (1975). Adaptation in natural and artificial systems. An introductory analysis with applications to biology, control, and artificial intelligence. The University of Michigan Press.
Horsh, R. B., Fry, J. E., Hoffmann, N. L., Eichholtz, D., Rogers, S. G., & Fraley, R. T. (1985). A simple and general method for transferring genes into plants. Science, 227, 1229-1231.
Huang, T. K., Plesha, M. A., Falk, B. W., Dandekar, A. M., & McDonald, K. A. (2009). Bioreactor strategies for improving production yield and functionality of a recombinant human protein in transgenic tobacco cell cultures. Biotechnology and Bioengineering, 102, 508-520.
Ishige, F., Takaichi, M., Foster, R., Chua, N. H., & Oeda, K. (1999). A G-box motif (GCCACGTGCC) tetramer confers high-level constitutive expression in dicot and monocot plants. The Plant Journal, 18, 443-448.
Ko, K., & Koprowski, H. (2005). Plant biopharming of monoclonal antibodies. Virus Research, 111, 93-100.
Liu, S., Bugos, R. C., Dharmasiri, N., & Su, W. W. (2001). Green fluorescent protein as a secretory reporter and a tool for process optimization in transgenic plant cell cultures. Journal of Biotechnology, 87, 1-16.
Lolas, A. (2013). Microbial control strategies in bioprocessing falling short of assuring product quality and satisfying regulatory expectations. American Pharmaceutical Review, 16.
Ma, J. K. C., Barros, E., Bock, R., Christou, P., Dale, P. J., Dix, P. J., Fischer, R., Irwin, J., Mahoney, R., Pezzotti, M., Schillberg, S., Sparrow, P., Stoger, E., & Twyman, R. M. (2005). Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Reports, 6, 593-599.
Moustafa, K., Makhzoum, A., & Trémouillaux-Guiller, J. (2016). Molecular farming on rescue of pharma industry for next generations. Critical Reviews in Biotechnology, 36, 840-850.
Muffler, K., Retzlaff, M., Van Pée, K.-H., & Ulber, R. (2007). Optimisation of halogenase enzyme activity by application of a genetic algorithm. Journal of Biotechnology, 127, 425-433.
Nagata, T., & Kumagai, F. (1999). Plant cell biology through the window of the highly synchronized tobacco BY-2 cell line. Methods in Cell Science, 21, 123-127.
Nagata, T., Nemoto, Y., & Hasezawa, S. (1992). Tobacco BY-2 cell line as the “HeLa” cell in the cell biology of higher plants. International Review of Cytology, 132, 1-30.
Nocarova, E., & Fischer, L. (2009). Cloning of transgenic tobacco BY-2 cells; an efficient method to analyse and reduce high natural heterogeneity of transgene expression. BMC Plant Biology, 9, 44.
Nuttall, J., Vine, N., Hadlington, J. L., Drake, P., Frigerio, L., & Ma, J. K. C. (2002). ER-resident chaperone interactions with recombinant antibodies in transgenic plants. European Journal of Biochemistry, 269, 6042-6051.
Rasool, S. I., & de Bergh, C. (1970). The runaway greenhouse and the accumulation of CO2 in the Venus atmosphere. Nature, 226, 1037-1038.
Salazar-Peña, R., Lippe, K., Alcaraz-González, V., & Franco-Lara, E. (2010). Advanced modelling for media composition optimization of phototrophic growth. IFAC Proceedings Volumes, 43, 419-424.
Sarawaneeyaruk, S., Iwakawa, H.oki, Mizumoto, H., Murakami, H., Kaido, M., Mise, K., & Okuno, T. (2009). Host-dependent roles of the viral 5′ untranslated region (UTR) in RNA stabilization and cap-independent translational enhancement mediated by the 3′ UTR of Red clover necrotic mosaic virus RNA1. Virology, 391, 107-118.
Shahid, N., & Daniell, H. (2016). Plant-based oral vaccines against zoonotic and non-zoonotic diseases. Plant Biotechnology Journal, 14, 2079-2099.
Sharma, A. K., & Sharma, M. K. (2009). Plants as bioreactors: Recent developments and emerging opportunities. Biotechnology Advances, 27, 811-832.
Sheludko, Y. V. (2008). Agrobacterium-mediated transient expression as an approach to production of recombinant proteins in plants. Recent Patents on Biotechnology, 2, 198-208.
Shinmyo, A., & Kato, K. (2010). Molecular farming: Production of drugs and vaccines in higher plants. The Journal of Antibiotics, 63, 431-433.
Sudarshana, M. R., Plesha, M. A., Uratsu, S. L., Falk, B. W., Dandekar, A. M., Huang, T. K., & McDonald, K. A. (2006). A chemically inducible cucumber mosaic virus amplicon system for expression of heterologous proteins in plant tissues. Plant Biotechnology Journal, 4, 551-559.
Vasilev, N., Grömping, U., Lipperts, A., Raven, N., Fischer, R., & Schillberg, S. (2013). Optimization of BY-2 cell suspension culture medium for the production of a human antibody using a combination of fractional factorial designs and the response surface method. Plant Biotechnology Journal, 11, 867-874.
Weuster-Botz, D. (2000). Experimental design for fermentation media development: Statistical design or global random search? Journal of Bioscience and Bioengineering, 90, 473-83.
Weuster-Botz, D., & Wandrey, C. (1995). Medium optimization by genetic algorithm for continuous production of formate dehydrogenase: A continuous production process for formate dehydrogenase (FDH) production. Process Biochemistry, 30, 563-571.
Xiong, Z., & Lommel, S. A. (1989). The complete nucleotide sequence and genome organization of red clover necrotic mosaic virus RNA-1. Virology, 171, 543-554.
Xu, J., Ge, X., & Dolan, M. C. (2011). Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnology Advances, 29, 278-299.
Yin, J., Li, G., Ren, X., & Herrler, G. (2007). Select what you need: A comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. Journal of Biotechnology, 127, 335-347.
Zuo, J., Niu, Q. W., & Chua, N. H. (2000). An estrogen receptor-based transactivator XVE mediates highly inducible gene expression in transgenic plants. The Plant Journal, 24, 265-273.

Auteurs

Jan Sadoch (J)

High-throughput Screening Laboratory, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.

Monika Pyc (M)

High-throughput Screening Laboratory, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.

Anna Urbanowicz (A)

Laboratory of Protein Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.

Adam Iglewski (A)

Department of Research and Development, Labomatica Ltd., Poznań, Poland.

Radosław Pilarski (R)

High-throughput Screening Laboratory, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH